-1167
Days Left
Lead Plaintiff Deadline: March 23, 2020
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
19
Mar 2018
26
Sep 2018
defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.
In order to be included in the lawsuit, you must have incurred a loss on shares of purchased or acquired during the class period listed above.
If you suffered a loss in during the relevant time frame, you have until March 23, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.